AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (June 24, 2009). doi:10.1152/ajprenal.00086.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/3/F729    most recent
00086.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Noh, H.
Right arrow Articles by Lee, H. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noh, H.
Right arrow Articles by Lee, H. B.
Submitted on February 13, 2009
Revised on June 3, 2009
Accepted on June 21, 2009

Histone Deacetylase 2 is a Key Regulator of Diabetes and Transforming Growth Factor-{beta}1-Induced Renal Injury

Hyunjin Noh1, Eun Young Oh2, Ji Yeon Seo1, Mi Ra Yu1, Young Ok Kim1, Hunjoo Ha2*, and Hi Bahl Lee3

1 Soon Chun Hyang University
2 Ewha Womans University
3 Soon Chun Hyang University,

* To whom correspondence should be addressed. E-mail: hha{at}ewha.ac.kr.

Excessive accumulation of extracellular matrix (ECM) in the kidneys and epithelial to mesenchymal transition (EMT) of renal tubular epithelial cells contribute to the renal fibrosis that is associated with diabetic nephropathy. Histone deacetylase (HDAC) determines the acetylation status of histones and, thereby, controls the regulation of gene expression. This study examined the effect of HDAC inhibition on renal fibrosis induced by diabetes or transforming growth factor (TGF)-{beta}1 and determined the role of reactive oxygen species (ROS) as mediators of HDAC activation. In streptozotocin (STZ)-induced diabetic kidneys and TGF-{beta}1 treated normal rat kidney tubular epithelial cells (NRK52-E), we found that trichostatin A, a non-selective HDAC inhibitor, decreased mRNA and protein expressions of ECM components and prevented EMT. Valproic acid and class I-selective HDAC inhibitor, SK-7041, also showed the similar effects in NRK52-E cells. Among the six HDACs tested (HDAC 1 through 5 and HDAC 8), HDAC 2 activity significantly increased in the kidneys of STZ-induced diabetic rats and db/db mice and TGF-{beta}1 treated NRK52-E cells. Levels of mRNA expression of fibronectin and {alpha}-smooth muscle actin were decreased while E-cadherin mRNA was increased when HDAC 2 was knocked down using RNA interference in NRK52-E cells. Interestingly, hydrogen peroxide increased HDAC 2 activity and the treatment with an antioxidant, N-acetylcystein, almost completely reduced TGF-{beta}1-induced activation of HDAC 2. These findings suggest that HDAC 2 plays an important role in the development of ECM accumulation and EMT in diabetic kidney and that ROS mediate TGF-{beta}1-induced activation of HDAC 2.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.